Report cover image

AI in MRI

Published May 01, 2026
Length 230 Pages
SKU # GJOB21159912

Description

REPORT HIGHLIGHTS

Global AI in MRI Market to Reach US$6.4 Billion by 2032

The global market for AI in MRI estimated at US$1.6 Billion in the year 2025, is expected to reach US$6.4 Billion by 2032, growing at a CAGR of 21.7% over the analysis period 2025-2032. Software Component, one of the segments analyzed in the report, is expected to record a 23.9% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 20.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$482.6 Million While China is Forecast to Grow at 20.5% CAGR

The AI in MRI market in the U.S. is estimated at US$482.6 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2032 trailing a CAGR of 20.5% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.4% and 18.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.8% CAGR.

Global Artificial Intelligence (AI) in MRI Market - Key Trends & Drivers Summarized

How Is Intelligent Reconstruction Changing Magnetic Resonance Imaging Workflows?

Artificial intelligence is redefining magnetic resonance imaging by transforming the way raw signal data is reconstructed into clinically interpretable images. Conventional MRI required long acquisition times to ensure sufficient signal quality, but learning based reconstruction now generates high fidelity images from fewer measurements. Systems learn relationships between k space data and anatomical structure allowing removal of noise and motion artifacts during reconstruction. This capability enables shorter scan durations while preserving diagnostic clarity which improves patient comfort and scanner utilization. Radiology departments schedule more examinations per day because faster protocols reduce queue time. Pediatric and elderly patients benefit particularly since reduced scan time minimizes the need for sedation. Image quality becomes consistent across operators because reconstruction parameters adapt automatically to patient anatomy. Real time reconstruction provides immediate feedback to technologists allowing corrections during acquisition rather than repeating entire sequences. Hospitals integrate reconstruction analytics with scanner controls so protocols optimize automatically for clinical indication. MRI transitions from a purely hardware dependent modality to a software defined imaging platform where reconstruction intelligence determines performance efficiency. The scanning experience evolves into a responsive process guided by adaptive algorithms.

Can AI Enhance Detection of Subtle Pathologies in Complex Tissues?

Magnetic resonance images contain complex contrasts representing tissue composition and physiological properties that may be difficult to interpret visually. Analytical models examine voxel level patterns across sequences to identify abnormalities that resemble early disease signatures. Neurological imaging benefits from automated detection of small lesions associated with neurodegenerative conditions and inflammatory disorders. Musculoskeletal studies gain improved identification of micro tears and cartilage degeneration through texture analysis. Cardiac imaging analytics evaluate motion patterns across heart cycles to reveal functional impairment before structural changes occur. Oncology applications detect tumor boundaries more precisely which assists treatment planning and monitoring. Quantitative MRI parameters such as diffusion and perfusion maps are interpreted automatically to classify tissue viability. Multisequence correlation helps differentiate benign from malignant findings using learned patterns derived from large datasets. Radiologists receive structured measurements and probability scores supporting consistent reporting. Continuous model training from confirmed diagnoses improves detection sensitivity across diverse patient populations. The modality therefore evolves into a measurement driven diagnostic tool rather than purely visual interpretation.

How Are MRI Systems Integrating Predictive Analytics Into Clinical Practice?

Healthcare providers increasingly connect MRI platforms with clinical information systems enabling contextual interpretation of imaging findings. Predictive models combine imaging features with patient history to estimate disease progression and treatment response probability. Workflow management systems prioritize urgent examinations based on automated analysis of incoming scans. Reporting platforms populate structured templates directly from analytical outputs reducing dictation effort. Follow up imaging comparisons are automated to highlight changes in lesion size or tissue characteristics across time. Research programs analyze aggregated imaging datasets to discover imaging biomarkers linked with therapeutic outcomes. Remote consultation services share annotated studies enabling specialists to review cases efficiently. Quality assurance analytics monitor scanner performance and detect calibration deviations affecting image consistency. Training programs incorporate annotated image libraries generated by analytical tools to educate radiology residents. The MRI suite becomes an integrated diagnostic hub where acquisition, interpretation and clinical decision making operate within a unified digital environment.

What Factors Are Driving Adoption of AI Enabled MRI Technologies?

The growth in the Artificial Intelligence in MRI market is driven by several factors including need to reduce scan duration while maintaining diagnostic image quality, increasing demand for quantitative imaging biomarkers supporting precision medicine, and rising imaging volumes requiring efficient radiology workflows. Adoption is also supported by expansion of neurological and oncological screening programs depending on consistent image interpretation, integration of imaging findings with electronic health records for predictive clinical assessment, and shortage of experienced radiologists encouraging automated measurement and prioritization tools. Pediatric imaging requirements motivate motion correction and rapid acquisition methods. Longitudinal disease monitoring drives automated comparison analytics across serial scans. Healthcare providers aim to standardize reporting formats across multiple sites encouraging analytical interpretation platforms. Equipment utilization optimization encourages adaptive protocol selection based on clinical indication. These imaging specific and operational factors collectively promote widespread implementation of intelligent MRI solutions across diagnostic and research settings.

SCOPE OF STUDY:

The report analyzes the AI in MRI market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (Software Component, Services Component, Hardware Component); Technology (Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology, Other Technologies); Application (Musculoskeletal Application, Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Research & Academic Institutes End-Use)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

SELECT PLAYERS -
  • Aitia
  • BioXcel Therapeutics
  • Clarify Health Solutions, Inc.
  • Freenome Holdings, Inc.
  • GE HealthCare PLC
  • IBM Corporation
  • K Health
  • Koninklijke Philips NV
  • Nanox Imaging
  • Nuance Communications, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

230 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
World Market Trajectories
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
Artificial Intelligence (AI) in MRI – Global Key Competitors Percentage Market Share in 2026 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Accelerated Image Reconstruction Drives Adoption of Faster MRI Scanning Workflows
Low Signal Data Enhancement Expands Addressable Market Opportunity for High Quality Imaging at Reduced Scan Time
Automated Protocol Selection Strengthens Business Case for Operator Independent MRI Operation
Radiologist Shortage Here`s How AI Assisted Interpretation Improves Reporting Throughput
Motion Correction Algorithms Spur Growth in Pediatric and Emergency MRI Applications
Quantitative Imaging Biomarkers Generate Demand for Disease Progression Monitoring Tools
Cloud Connected Imaging Platforms Enable Collaborative Model Training Across Healthcare Networks
Predictive Maintenance Analytics Throw the Spotlight On Uptime Optimization for MRI Systems
Contrast Free Imaging Techniques Drive Adoption of Safer Patient Friendly MRI Procedures
Integrated Oncology Workflows Propel Deployment of Tumor Detection and Characterization AI
Workflow Automation Sustains Growth in End to End Radiology Information Ecosystems
Hybrid Imaging Modalities Expand Opportunities for Multimodal Diagnostic Intelligence
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World AI in MRI Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
TABLE 2: World Recent Past, Current & Future Analysis for AI in MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 3: World 8-Year Perspective for AI in MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2026 & 2032
TABLE 4: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 5: World 8-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 7: World 8-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 9: World 8-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 10: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 11: World 8-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 12: World Recent Past, Current & Future Analysis for Liver Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 13: World 8-Year Perspective for Liver Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 15: World 8-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 16: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 17: World 8-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 18: World Recent Past, Current & Future Analysis for Prostate Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 19: World 8-Year Perspective for Prostate Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 20: World Recent Past, Current & Future Analysis for Fetal & Neonatal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 21: World 8-Year Perspective for Fetal & Neonatal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 22: World Recent Past, Current & Future Analysis for Other Applications Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 23: World 8-Year Perspective for Other Applications Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 24: World Recent Past, Current & Future Analysis for Musculoskeletal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 25: World 8-Year Perspective for Musculoskeletal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 27: World 8-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 28: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 29: World 8-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 30: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 31: World 8-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 33: World 8-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 34: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 35: World 8-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 36: World Recent Past, Current & Future Analysis for Deep Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 37: World 8-Year Perspective for Deep Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 38: World Recent Past, Current & Future Analysis for Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 39: World 8-Year Perspective for Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 40: World Recent Past, Current & Future Analysis for Computer Vision Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 41: World 8-Year Perspective for Computer Vision Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 42: World Recent Past, Current & Future Analysis for Natural Language Processing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 43: World 8-Year Perspective for Natural Language Processing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
TABLE 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 45: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
TABLE 46: USA Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 47: USA 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 48: USA Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 49: USA 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 50: USA Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 51: USA 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 52: USA Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 53: USA 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
CANADA
TABLE 54: Canada Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 55: Canada 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 56: Canada Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 57: Canada 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 58: Canada Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 59: Canada 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 60: Canada Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 61: Canada 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
JAPAN
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
TABLE 62: Japan Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 63: Japan 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 64: Japan Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 65: Japan 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 66: Japan Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 67: Japan 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 68: Japan Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 69: Japan 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
CHINA
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
TABLE 70: China Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 71: China 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 72: China Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 73: China 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 74: China Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 75: China 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 76: China Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 77: China 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
EUROPE
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
TABLE 78: Europe Recent Past, Current & Future Analysis for AI in MRI by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 79: Europe 8-Year Perspective for AI in MRI by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2026 & 2032
TABLE 80: Europe Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 81: Europe 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 82: Europe Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 83: Europe 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 84: Europe Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 85: Europe 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 86: Europe Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 87: Europe 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
FRANCE
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
TABLE 88: France Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 89: France 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 90: France Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 91: France 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 92: France Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 93: France 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 94: France Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 95: France 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
GERMANY
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
TABLE 96: Germany Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 97: Germany 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 98: Germany Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 99: Germany 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 100: Germany Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 101: Germany 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 102: Germany Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 103: Germany 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 105: Italy 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 106: Italy Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 107: Italy 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 108: Italy Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 109: Italy 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 110: Italy Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 111: Italy 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
UNITED KINGDOM
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
TABLE 112: UK Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 113: UK 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 114: UK Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 115: UK 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 116: UK Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 117: UK 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 118: UK Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 119: UK 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
REST OF EUROPE
TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 121: Rest of Europe 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 123: Rest of Europe 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 125: Rest of Europe 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 127: Rest of Europe 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
ASIA-PACIFIC
AI in MRI Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 129: Asia-Pacific 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 131: Asia-Pacific 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 133: Asia-Pacific 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 135: Asia-Pacific 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
REST OF WORLD
TABLE 136: Rest of World Recent Past, Current & Future Analysis for AI in MRI by Component - Software Component, Services Component and Hardware Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 137: Rest of World 8-Year Perspective for AI in MRI by Component - Percentage Breakdown of Value Sales for Software Component, Services Component and Hardware Component for the Years 2026 & 2032
TABLE 138: Rest of World Recent Past, Current & Future Analysis for AI in MRI by Application - Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 139: Rest of World 8-Year Perspective for AI in MRI by Application - Percentage Breakdown of Value Sales for Oncology Application, Liver Application, Cardiovascular Application, Neurology Application, Prostate Application, Fetal & Neonatal Application, Other Applications Application and Musculoskeletal Application for the Years 2026 & 2032
TABLE 140: Rest of World Recent Past, Current & Future Analysis for AI in MRI by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 141: Rest of World 8-Year Perspective for AI in MRI by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Research & Academic Institutes End-Use for the Years 2026 & 2032
TABLE 142: Rest of World Recent Past, Current & Future Analysis for AI in MRI by Technology - Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 143: Rest of World 8-Year Perspective for AI in MRI by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Machine Learning Technology, Computer Vision Technology, Natural Language Processing Technology and Other Technologies for the Years 2026 & 2032
IV. COMPETITION
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.